Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (Complete-PsA).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms COMPLETE- PsA
- Sponsors Abbott Canada; AbbVie
- 28 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 17 Jul 2017 Planned End Date changed from 1 Jun 2020 to 30 Nov 2019.
- 17 Jul 2017 Planned primary completion date changed from 1 Jun 2020 to 30 Nov 2019.